NCT04225988 - Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

July 11, 2023

Study Completion Date

July 11, 2023

Conditions

Kidney Transplant Rejection

Interventions

DRUG

Extended-release tacrolimus

Patients will receive the extended-release formulation of tacrolimus for maintenance immunosuppression.

DRUG

Immediate-release tacrolimus

Patients will receive the immediate-release formulation of tacrolimus for maintenance immunosuppression.

Trial Locations (1)

Cedars-Sinai Medical Center, Los Angeles